Patients will benefit if Europe modernizes its policy framework to reflect the distinct promise of cell and gene therapy, the Alliance for Regenerative Medicine will highlight on November 29 European Parliament event
Ppatients will benefit if Europe modernizes his political framework to reflect the distinct promise of cell and gene therapythe Alliance for Regenerative Medicine will highlight in November 29 European Parliament an event The event will feature the first pediatric patient to receive CAR-T therapy and focus on policy recommendations reverse The decline of Europecompetitiveness BRUSSEL …